Cofactors affecting the progression of HIV infection;LES COFACTEURS DANS L'EVOLUTION DE L'INFECTION PAR LE VIH

Presse Medicale

Volumn 25, Issue 8, 1996, Pages 379-384

  Meyer, L ^a   Carre N ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CHILD; COHORT ANALYSIS; FEMALE; FRANCE; INFANT; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR; SEXUAL BEHAVIOR; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 0030562607     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Alcabez P, Muñoz A, Vlahov D, Friedland G. Incubation period of Human Immunodeficiency Virus. Epidemiol Rev 1993; 15:303-18.
2. Cao Y, Qin L, Zhang L, Safrit J, Ho D Virologic and immunologic characterization of long-term survivors of Human Immunodeficiency Virus type 1 infection N Engl J Med 1995; 332 201-8.
3. Wei X, Ghosh SK, Taylor M et al Viral dynamics in Human Immunodeficiency Virus type 1. Nature 1995; 373:117-22.
4. Ho D, Neumann A, Perelson I et al. Rapid turn-over of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
5. Hessol NA, Koblin BA, van Griensven GJP et al. Progression of HIV-1 infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City and San Francisco, 1978-91. Am J Epidemiol 1994; 139:1077-87.
6. Goedert JJ, Kessler CM, Aledort LM et al. A prospective study of HIV-1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321:1141-8.
7. Bucquet D, Deveau C, Belanger F et al. et le groupe SEROCO. Cohorte française d'adultes infectés par le VIH: description et évolution après 4 ans de suivi. Presse Med 1994; 23:1247-51.
8. Blanche S, Mayaux MJM, Rouzioux C et al. and the French pediatric HIV infection study group. Relation of the course of HIV infection in children to the severity of the disease of the disease in their mothers at delivery. N Engl J Med 1994; 330:308-12.
9. Jaffé HW, Darrow WW, Echenberg DF et al. The AIDS in a cohort of homosexual men. Ann Intern Med 1985; 103:210-14
10. Blaxhult A, Granath F, Lidman K, Giesecke J The influence of age on the latency period to AIDS in people infected through blood transfusion. AIDS 1990; 4:125-9.
11. Veugelers PJ, Page KA, Tindall B et al. Determinants of HIV disease progression among homosexual men registered in the tricontinental seroconverter study. Am J Epidemiol 1994; 140:747-58
12. MAP Workshop. Markers as time-dependent covariates in relative risk regression. Stat Med 1993; 12:2087-98
13. Phillips AN, Lee CA, Elford J et al. More rapid progression to AIDS in older HIV-infected people : the role of CD4+ T-cell counts. J Acq Immune Defic Synd 1991; 4:970-5.
14. Klein MR, Keet IPM, d'Amaro J et al. Associations between HLA frequencies and pathogenic features of HIV-1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994; 169:1244-9.
15. Ward JW, Bush TJ, Perkins HA et al The natural history of transfusion-associated infection with HIV virus. N Engl J Med 1989; 321:947-52.
16. Ashton L, Learmont J, Luo K, Wylie B, Stewart G, Kaldor J HIV infection in recipients of blood products from donors with known duration of infection. Lancet 1994; 344:718-20
17. Polk BF, Fox R, Brookmeyer R et al Predictors of AIDS developing in a cohort of seropositive homosexual men N Engl J Med 1987; 316:61-6
18. Van Griensven GJP, de Vroom EMM, de Wolf F, Goudsmit J, Roos M, Coutinho RA. Risk factors for progression of HIV infection among seroconverted and seropositive homosexual men. Am J Epidemiol 1990; 132:203-10.
19. Carré N, Meyer L, Boufassa F et al. and the SEROCO study group. High risk of HIV disease progression after sexual infection through a partner with AIDS. AIDS 1996; 10:77-80
20. Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 correlate with virulence in the host Science 1988; 240:80-2.
21. Pedersen C, Linhardt BO, Jensen BL et al Clinical course of primary HIV infection, consequences for subsequent course of infection Br Med J 1989; 299:154-7
22. Boufassa F, Bachmeyer C, Carré N et al and SEROCO study group. Influence of neurologic manifestations of primary HIV infection in disease progression J Infect Dis 1995; 171:1190-5.
23. Mellors JW, Kingsley LA, Rinaldo CR et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-9.
24. Rosenberg PS, Goedert JJ, Biggar RJ for the Multicenter Hemophilia Cohort Study and the International Registry of seroconverters. Effect of age at seroconversion on the natural AIDS incubation distribution AIDS 1994; 8:803-10.
25. Carré N, Deveau C, Belanger F et al and the SEROCO study group. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8:797-802.
26. Webster A, Lee CA, Cook DG et al. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with HIV infection. Lancet 1989; ii:63-6
27. Rabkin CS, Hatzakis A, Griffiths PD et al and the National Cancer Institute Multicenter Hemophilia Cohort Study Group. Cytomegalovirus infection and risk of AIDS in HIV-infected hemophilia patients. J Infect Dis 1993; 168:1260-3.
28. Hershow R, Fukuda K, Graber J et al. Does HTLV-II coinfection predict clinical progression in HIV-infected drug users? PC0210. Xth International Conference on AIDS. Yokohama, 1994.
29. Chavance M, Naisson-Vernant C, Quist D, Monplaisir N, Armengaud B, Chout R HIV/HTLV-1 coinfection and clinical grade at diagnosis. J Acq Immune Defic Synd 1995; 8:91-5
30. Brookmeyer R, Gail MH, Polk BF. The prevalent cohort and the acquired immunodeficiency syndrome Am J Epidemiol 1987; 126:14-24
31. Grau O, Slizewicz B, Tuppin P et al. Association of Mycoplasma penetrans with Human Immunodeficiency Virus infection J Infect Dis 1995; 172:672-81
32. Hocke C, Morlat P, Chêne G, Dequae L, Dabis F and the GECSA group. Prospective cohort study of the effect of pregnancy on the progression of HIV infection. Obstet Gynecol 1995, 86 886-91
33. Phillips AN, Sabin CA, Mocroft A Active drug injecting and progression of HIV infection. AIDS 1994; 8:385-6.
34. Cozzi Lepri A, Pezzotti P, Dorrucci M, Philipps AN, Rezza G, and the Italian Seroconversion Group. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Br Med J 1994; 309:1537-42
35. Concorde coordinating committee. Concorde MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343:871-81.